Navigation Links
FDA Grants 510(k) Clearance to Life Technologies Stem Cell Growth Medium
Date:3/14/2011

"A key component for stem cell research to advance into clinical trials and beyond is the ability to put validated tools into the hands of researchers who are working to make cell therapy a reality," says Joydeep Goswami, Head of Primary & Stem Cells at Life Technologies.  "The 510(k) clearance by the FDA of our StemPro MSC SFM is a pivotal step in that direction, and reinforces Life Technologies' commitment to providing higher-quality and innovative solutions to our customers."

About Life Technologies (www.lifetechnologies.com)

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products. Life Technologies' industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, GIBCO, Ambion, Molecular Probes and Taqman products. Life Technologies had sales of $3.6 billion in 2010, has a workforce of approximately 11,000 people, has a presence in approximately 160 countries, and possesses one of the largest intellectual property estates in the life sciences industry, with approximately 3,900 patents and exclusive licenses. For more information on how we are making a difference, pleas
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Court Grants Preliminary Approval to Class Action Settlement that Provides Benefits Of Approximately $20 Million to Healthcare Providers that Purchased a SS1 Before January 1, 2009
2. Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3. FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder
4. Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe
5. FTC Grants Early Termination of Waiting Period Under Hart-Scott-Rodino Act
6. FDA Grants Orphan Drug Designation to Bayers Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal Tumors
7. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
8. NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
9. HA&W Obtains Approximately $2 M in Credits and Cash Grants for Clients Through the Therapeutic Discovery Project Program
10. Generex Oncology Awarded Two IRS Therapeutic Discovery Project Grants
11. NovaSperse(SM) Nanoparticle Innovator, PharmaNova, Inc., Awarded Four Government Grants Toward Development of New Therapeutic Products Under Congressional Qualifying Therapeutic Discovery Project Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) announces that ... to the announced tender offer for all of the outstanding shares ... of the waiver, the transaction is no longer conditional on OFT ... 24, 2014 following the currently scheduled expiration time, subject to the ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and distributors ... able to protect their most important business assets, ... ) Because of the highly-competitive ... remains one of the most litigious industry sectors ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. ... a U.S. provisional patent application concerning composition of matter, ... achieve targeted tumor cell death.  This ... noncoding double stranded RNA molecules (VSRNAs) which interfere with ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... Hill-Rom Holdings, Inc., (NYSE: HRC ) invites you to listen to a ... the Goldman Sachs 31st Annual Global Health Care Conference in Los Angeles ... 10:40 a.m. PDT ).     , , ... invited to listen to the live discussion via the internet link at http://ir.hill-rom.com/events.cfm ...
... June 2 Today In the Face of ... help pain management advocates expand their outreach efforts through popular ... to social media applications, such as Facebook, and walks users ... communication vehicles. Topics include "An Overview of Social Media," "Advocacy ...
Cached Medicine Technology:Hill-Rom to Participate at the Goldman Sachs 31st Annual Global Health Care Conference 2In the Face of Pain® Offers Social Media 101 for Pain Management Advocates 2
(Date:4/17/2014)... million older Americans suffer from depression, often brought on ... research a project that followed the lives of ... found that Internet use among the elderly can reduce ... , "That,s a very strong effect," said Shelia Cotten, ... and media who led the project. "And it all ...
(Date:4/17/2014)... YORK April 17, 2014 EcoHealth Alliance, a ... health issues, published a comprehensive review today examining the ... Marburg virus. The review calls for improved global surveillance ... as the recent outbreak of Ebola in West Africa ... the countries of Guinea and Liberia. According to ...
(Date:4/17/2014)... uncommon these days to find a colored ribbon representing a ... cancer. But what color ribbon does one think of with ... color, for many suffering from the disease, black may be ... study consisting of lung cancer patients, primarily smokers between the ... light on the stigma often felt by these patients, the ...
(Date:4/17/2014)... TORONTO, April 17, 2014While 94 per cent of Canadians ... that screen newborns for a specific number of genetic ... willing to participate in screening that would sequence their ... prick test" in their first day or two of ... taken from their heels and tested for about five ...
(Date:4/16/2014)... the embryo. It begins as a glob of identical cells ... the cells of our lungs, muscles, nerves and all the ... feat of reverse tissue engineering, Stanford University researchers have begun ... to proliferate and transform into all of the specialized cells ...
Breaking Medicine News(10 mins):Health News:Internet use can help ward off depression among elderly 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:Researcher looks at public perceptions around newborn testing 2Health News:Researcher looks at public perceptions around newborn testing 3Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 3
... Researchers have found that contacting with Age-related Macular Degeneration ... whose Body Mass Index is 30 or higher//. ... risk and high BMI (30 or higher) was associated ... risk genotype (CC) plus smoking conferred a tenfold higher ...
... transdermal system), formulated by Shire was the foremost patch ... ,Transdermal formulation of methylphenidate - DAYTRANA, is ... 10 mg, 15 mg, 20 mg and 30 mg. ... for ADHD, provides physicians and parents with a new, ...
... the National Health Service (NHS) information centre the Scots are ... and the number of NHS dentist//. ,They fear ... demand. The British Dental Association said that the NHS is ... the NHS information and statistics division, it is found that ...
... vaccines, each developed by Merck and Smith Glaxo Kline has ... cancers caused by the human papilloma viruses (HPVs). ... showed reduced infection in about 90% of the subjects. ... and immunologic technologies have contributed to the discovery of the ...
... Recent research has revealed that having several older brothers increases ... finding that adds //weight to the idea of a biological ... of Brock University in St Catharines, Canada said, "It's likely ... that there is probably a biological basis for homosexuality." ...
... and Pharmacovigilance said that FDA’s approval of REVLIMID ... the group of people suffering from multiple myeloma. ... the U.S. Food and Drug Administration (FDA) has ... (sNDA) for an additional indication for REVLIMID (lenalidomide), ...
Cached Medicine News:Health News:Cigarette Smoking and High Body Mass Index Increase the Risk of AMD 2Health News:Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom 2Health News:Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom 3Health News:Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: